Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Yale Center for Analytic Sciences, Yale School of Public Health, New Haven, CT, USA.
Transl Behav Med. 2022 Jul 7;12(6):726-733. doi: 10.1093/tbm/ibac022.
Tobacco use disorder (TUD) is a major threat to health among people with HIV (PWH), but it is often untreated. Among HIV clinicians and staff, we sought to characterize practices, attitudes, and confidence addressing TUD among PWH to identify potential opportunities to enhance provision of care. Cross-sectional deidentified, web-based surveys were administered from November 4, 2020 through December 15, 2020 in HIV clinics in three health systems in the United States Northeast. Surveys assessed provider characteristics and experience, reported practices addressing tobacco use, and knowledge and attitudes regarding medications for TUD. Chi-square tests or Fisher's exact tests were used to examine differences in responses between clinicians and staff who were prescribers versus nonprescribers and to examine factors associated with frequency of prescribing TUD medications. Among 118 survey respondents (56% prescribers), only 50% reported receiving prior training on brief smoking cessation interventions. Examining reported practices identified gaps in the delivery of TUD care, including counseling patients on the impact of smoking on HIV, knowledge of clinical practice guidelines, and implementation of assessment and brief interventions for smoking. Among prescribers, first-line medications for TUD were infrequently prescribed and concerns about medication side effects and interaction with antiretroviral treatments were associated with low frequency of prescribing. HIV clinicians and staff reported addressable gaps in their knowledge, understanding, and practices related to tobacco treatment. Additional work is needed to identify ways to ensure adequate training for providers to enhance the delivery of TUD treatment in HIV clinic settings.
烟草使用障碍(TUD)是 HIV 感染者(PWH)健康的主要威胁,但往往未得到治疗。在 HIV 临床医生和工作人员中,我们试图描述针对 PWH 的 TUD 治疗的实践、态度和信心,以确定增强护理提供的潜在机会。2020 年 11 月 4 日至 12 月 15 日,在美国东北部的三个医疗系统的 HIV 诊所,通过匿名网络调查,对临床医生和工作人员进行了横断面调查。调查评估了提供者的特征和经验、报告的烟草使用治疗实践以及针对 TUD 药物的知识和态度。使用卡方检验或 Fisher 精确检验,比较了开具与不开具 TUD 药物的临床医生和工作人员的反应差异,并检验了与开具 TUD 药物频率相关的因素。在 118 名调查受访者(56%为开具者)中,只有 50%的人报告之前接受过简短戒烟干预的培训。检查报告的实践发现,在提供 TUD 护理方面存在差距,包括向患者告知吸烟对 HIV 的影响、了解临床实践指南以及实施吸烟评估和简短干预。在开具者中,TUD 的一线药物很少开具,对药物副作用和与抗逆转录病毒治疗相互作用的担忧与开具药物的频率较低有关。HIV 临床医生和工作人员报告在与烟草治疗相关的知识、理解和实践方面存在可解决的差距。需要进一步努力,确定确保提供者获得足够培训的方法,以加强 HIV 诊所环境中 TUD 治疗的提供。